MedPath
NMPA Approval

Infliximab for Injection

国药准字SJ20171001

June 16, 2021

S20171001

Drug Information

注射用英夫利西单抗

类克

注射剂

100mg/支

生物制品

June 16, 2021

June 15, 2026

Company Information

Applicant Company

Einsteinweg 101, 2333 CB Leiden, The Netherlands

Manufacturing Company

Cilag AG

Hochstrasse 201, CH-8200 Schaffhausen, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用英夫利西单抗 - NMPA 批准文号 | MedPath